Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer ; volume:135 ; number:1 ; day:29 ; month:7 ; year:2012 ; pages:241-252 ; date:8.2012
Breast cancer research and treatment ; 135, Heft 1 (29.7.2012), 241-252, 8.2012
- Creator
-
Boer, Richard H. De
Kotasek, Dusan
White, Shane
Koczwara, Bogda
Mainwaring, Paul
Chan, Arlene
Melara, Rebeca
Ye, Yining
Adewoye, Adeboye H.
Sikorski, Robert
Kaufman, Peter A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-012-2135-0
- URN
-
urn:nbn:de:101:1-2019101518585065717094
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boer, Richard H. De
- Kotasek, Dusan
- White, Shane
- Koczwara, Bogda
- Mainwaring, Paul
- Chan, Arlene
- Melara, Rebeca
- Ye, Yining
- Adewoye, Adeboye H.
- Sikorski, Robert
- Kaufman, Peter A.
- SpringerLink (Online service)
Other Objects (12)
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Mortality not correlated with Paclitaxel exposure
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
Nanoparticle Polymeric Micellar Paclitaxel Versus Paclitaxel for Patients with Advanced Gastric Cancer
Palliative Therapie des rezidivierten Kopf-Hals-Karzinoms : ein retrospektiver Vergleich der Taxane Paclitaxel und Docetaxel
Finding purifications with minimal entanglement
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Mortality not correlated with Paclitaxel exposure
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
Nanoparticle Polymeric Micellar Paclitaxel Versus Paclitaxel for Patients with Advanced Gastric Cancer
Palliative Therapie des rezidivierten Kopf-Hals-Karzinoms : ein retrospektiver Vergleich der Taxane Paclitaxel und Docetaxel
Finding purifications with minimal entanglement
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Mortality not correlated with Paclitaxel exposure
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
Nanoparticle Polymeric Micellar Paclitaxel Versus Paclitaxel for Patients with Advanced Gastric Cancer
Palliative Therapie des rezidivierten Kopf-Hals-Karzinoms : ein retrospektiver Vergleich der Taxane Paclitaxel und Docetaxel
Finding purifications with minimal entanglement
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells